Mayo Clinic researchers have discovered that people with major depressive disorder and a history of attempted suicide have distinct biomarkers that correlate with their response to antidepressant therapy. The new findings, published in Frontiers in Pharmacology, are key to individualized treatment strategies and early identification of patients who are at the highest risk for suicide.